CPS Technologies (CPSH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
10 Mar, 2026Executive summary
The annual meeting is scheduled for April 30, 2026, with voting on five key proposals, including director elections, executive compensation, share authorization, and auditor ratification.
Only stockholders of record as of March 11, 2026, are entitled to vote, with 18,006,780 shares outstanding.
Proxy materials are available online, and voting can be done via internet, phone, mail, or in person.
Voting matters and shareholder proposals
Proposals include electing five directors, advisory votes on executive compensation and its frequency, increasing authorized common stock from 20M to 25M shares, and ratifying PKF O'Connor Davies LLP as auditor.
The board recommends voting for all director nominees, for executive compensation, for annual say-on-pay votes, for the share increase, and for auditor ratification.
Shareholder proposals for the 2027 meeting must be received by November 20, 2026.
Board of directors and corporate governance
The board consists of five independent directors, each meeting Nasdaq independence standards.
Directors and nominees bring diverse experience in management, finance, academia, and industry.
The board held six meetings in 2025, with all directors attending at least 75% of meetings.
Two standing committees: Audit and Compensation/Nominating, both with independent members.
Policies encourage diversity, ethics, and open stockholder communication.
Latest events from CPS Technologies
- 2026 meeting seeks approval for directors, executive pay, share increase, and auditor ratification.CPSH
Proxy filing20 Mar 2026 - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 20253 Mar 2026 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 20242 Feb 2026 - Record Q2 2025 revenue, profitability, and strong demand drive a positive outlook.CPSH
Q2 202529 Jan 2026 - Record revenue, margin gains, and a $9.5M raise drive expansion and strong growth outlook.CPSH
Q3 202529 Jan 2026 - Record Q1 2025 revenue and profitability, with strong growth and improved margins.CPSH
Q1 202529 Jan 2026 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 202429 Jan 2026 - Record revenue, $12M order, and new contracts drive growth and innovation outlook.CPSH
21st Virtual Investor Summit Microcap Event12 Jan 2026 - Sequential revenue growth and new contracts position the company for a stronger 2025.CPSH
Q4 202426 Dec 2025